CROI 2016 Program at a Glance

Program and Agenda

498 Protease Inhibitor Resistance at 2nd-line HIV Treatment Failure in Sub-Saharan Africa Tamara Sonia Boender 1 ; Raph Hamers 1 ; Pascale Ondoa 1 ; Maureen Wellington 2 ; Margaret Siwale 3 ; Cissy Kityo 4 ; Sulaimon Akanmu 5 ; Kishor Mandaliya 6 ;Tobias Rinke deWit 1 ; Kim Sigaloff 1 ; for the PanAfrican Studies to Evaluate Resistance (PASER) study group 1 Amsterdam Inst forGlobalHlthandDevelop,Amsterdam,Netherlands; 2 NewlandsClinic,Harare,Zimbabwe; 3 LusakaTrustHosp,Lusaka, Zambia; 4 JointClinicalRsrCntr,Kampala,Uganda; 5 LagosUnivTeaching Hosp,Lagos,Nigeria; 6 CoastProvinceGeneralHosp,Mombasa,Kenya 499 Genome-Wide Association of HIVWhole Genomes Provides Insights Into Drug Resistance Robert A. Power 1 ; Siva Davaniah 1 ; Anne Derache 2 ; EduanWilkinson 1 ; FrankTanser 2 ; Ravindra K. Gupta 3 ; Deenan Pillay 2 ;Tulio de Oliveira 4 1 WellcomeTrustAfricaCntr forHlthandPopStudies,Somkhele,South Africa; 2 AfricaCntr forHlthandPopStudies,Mtubatuba,SouthAfrica; 3 UnivCollLondon,London,UK; 4 UnivofKwaZulu-Natal,Durban,South Africa 500 Receipt and Timing of Genotypic HIV Drug Resistance Testing in the United States Sharoda Dasgupta 1 ; H. Irene Hall 1 ; Angela L. Hernandez 1 ; M. Cheryl Banez Ocfemia 1 ; Neeraja Saduvala 2 ; Alexandra M. Oster 1 1 CDC,Atlanta,GA,USA; 2 ICF Intl,Atlanta,GA,USA 501 HIV Integrase Genotypic Resistance Testing Among HIV-Infected Persons in New York ZhengyanWang 1 ; Daniel Gordon 1 ; EmilyWalits 2 ; Joanne Gerber 1 ; Deepa Rajulu 1 ; Lou Smith 1 ; Bridget Anderson 1 1 NewYorkStateDeptofHlth,Albany,NY,USA; 2 UnivofAlbanySchofPH, Albany,NY,USA 502 Immunologic Criteria Are Poor Predictors of Virologic Outcomes in Nigeria Nicaise Ndembi 1 ; Fati M. Ibrahim 1 ; James Okuma 1 ; Ahmad Aliyu 1 ; Samuel Peters 1 ; Charles Mensah 1 ; Alash’le Abimiku 2 ; Clement Adebamowo 2 ; Manhattan E. Charurat 3 ; Patrick Dakum 1 1 InstofHumanVirology,Abuja,Nigeria; 2 InstofHumanVirology,Univ ofMarylandSchofMed,Baltimore,MD,USA; 3 InstofHumanVirology, Baltimore,MD,USA 503 Global Tenofovir Resistance Following 1st-Line Regimens for Adult HIV-1 Infection John Gregson 1 ; MichelleTang 2 ; Nicaise Ndembi 3 ; Raph Hamers 4 ; Vincent C. Marconi 5 ; Elliot Raizes 6 ; Rami Kantor 7 ; RobertW. Shafer 2 ; Ravindra K. Gupta 8 ; for theTenoRes StudyTeam 1 LondonSchofHygiene&TropMed,London,UK; 2 StanfordUniv, Stanford,CA,USA; 3 InstofHumanVirology,Abuja,Nigeria; 4 Amsterdam Inst forGlobalHlthandDevelop,Amsterdam,Netherlands; 5 EmoryUniv SchofMed,Atlanta,GA,USA; 6 CDC,Atlanta,GA,USA; 7 BrownUniv, Providence,RI,USA; 8 UnivCollLondon,London,UK

Session P-M2 Poster Abstracts

Hall A/B

2:45 PM-4:00 PM HIV Detection in Clinical Trials 521 4th Generation Rapid Tests Improve Detection of Acute Infection in MTN-003 (VOICE) Edward Livant 1 ; Amy L. Opest 2 ; CliftonW. Kelly 3 ; Rashika Maharaj 4 ; Natasha Samsunder 5 ; Rosetta Lindiwe Nhlangulela 6 ; Patrick Karugaba 7 ; Jeanne Marrazzo 8 ; Z Michael Chirenje 9 ; Urvi M. Parikh 2 ; for theVOICE StudyTeam 1 Magee-WomensHospof theUnivofPittsburghMedCntr,Pittsburgh,PA, USA; 2 UnivofPittsburgh,Pittsburgh,PA,USA; 3 FredHutchinsonCancer RsrCntr,Seattle,WA,USA; 4 SouthAfricanMedRsrCouncil,Durban, SouthAfrica; 5 Cntr for theAIDSProgofRsr inSouthAfrica,Durban,South Africa; 6 Aurum Inst forHlthRsr, Johannesburg,SouthAfrica; 7 Makerere Univ JohnsHopkinsUnivRsrCollabLab,Kampala,Uganda; 8 Univof Washington,Seattle,WA,USA; 9 UnivofZimbabwe,UnivofCaliforniaSan FranciscoCollaborativeRsrProg,Harare,Zimbabwe 522 Usefulness of Rapid Tests for HIV Diagnosis in the ANRS IPERGAY PrEP Trial Constance Delaugerre 1 ; Isabelle Charreau 2 ; Nadia Mahjoub 3 ; Eric Cua 4 ; Armelle Pasquet 5 ; Nolween Hall 6 ; Marie Laure Chaix 7 ; Guillemette Antoni 2 ; Jean-Michel Molina 8 ; for the IPERGAY study group 1 HospSaintLouisetUnivParisDiderot,Paris,France; 2 INSERMSC10- US19,Villejuif,France; 3 HospSaint-Louis,Paris,France; 4 Hospde l’Archet, Paris,France; 5 DRONHosp,Tourcoing,France; 6 CISIH,Nantes,France; 7 INSERMU941,UnivParisDiderot,Paris,France; 8 HopitalSaint-Louis, Paris,France 523 Use of an Automated Assay to Identify HIV Infections in a Population Survey in Africa Estelle Piwowar-Manning 1 ; ShaunaWolf 1 ; Kelsey Donohue 1 ; Anelet James 2 ; Barry Kosloff 3 ; AliciaYoung 4 ; Gert U. van Zyl 5 ; Helen Ayles 6 ; Richard Hayes 6 ; Susan H. Eshleman 1 1 JohnsHopkinsUnivSchofMed,Baltimore,MD,USA; 2 DesmondTutu TBCntr,StellenboschUniv,CapeTown,SouthAfrica; 3 ZAMBART,Lusaka, Zambia; 4 SCHARP,Seattle,WA,USA; 5 StellenboschUnivandNHLS TygerbergBusinessUnit,Tygerberg,SouthAfrica; 6 LondonSchofHygiene &TropMed,London,UK 524 HIV Testing in the US PrEP Demonstration Project: rEIA vs Antigen/Antibody vs RNA Oliver Bacon 1 ; EricVittinghoff 2 ; Stephanie Cohen 1 ; Susanne Doblecki- Lewis 3 ; Megan Coleman 4 ; Susan P. Buchbinder 1 ;Wairimu Chege 5 ; Richard Elion 6 ; Michael Kolber 3 ; AlbertY. Liu 1 1 SanFranciscoDeptofPH,SanFrancisco,CA,USA; 2 UnivofCalifornia SanFrancisco,SanFrancisco,CA,USA; 3 UnivofMiami,Miami,FL,USA; 4 Whitman-WalkerHlth,Washington,DC,USA; 5 DAIDS,NIAID,NIH, Bethesda,MD,USA; 6 GeorgeWashingtonUnivSchofMed,Washington, DC,USA

Poster Listings

87

CROI 2016